Ironwood Pharmaceuticals inc
Officers & Directors
1. Mark Mallon - Chief Executive Officer: Mark Mallon was appointed as the Chief Executive Officer of Ironwood Pharmaceuticals in 2020. He has more than 25 years of experience in the pharmaceutical and biotechnology industries, including senior leadership roles at AstraZeneca and Novartis.
2. Gina Consylman - Chief Commercial Officer: Gina Consylman joined Ironwood in 2017 and was appointed as the Chief Commercial Officer in 2019. She has over 25 years of experience in commercial operations, including serving as the President of Jazz Pharmaceuticals.
3. Tom Graney - Chief Financial Officer: Tom Graney has served as the Chief Financial Officer since 2014. He has over 20 years of experience in finance and operations, including serving as the Chief Financial Officer of Keryx Biopharmaceuticals.
4. Mark Currie - Chief Scientific Officer and President of Research & Development: Mark Currie has been the Chief Scientific Officer and President of Research & Development since 2014. He has over 30 years of pharmaceutical research and development experience, including serving as the Vice President of Immunology Research at Merck.
5. Halley Gilbert - Chief Legal Officer and Corporate Secretary: Halley Gilbert joined Ironwood in 2014 and was appointed as the Chief Legal Officer and Corporate Secretary in 2019. She has over 20 years of experience in legal and corporate governance, including serving as the Senior Vice President and General Counsel at Keryx Biopharmaceuticals.
6. Lawrence Olanoff - Chairman of the Board: Lawrence Olanoff has been the Chairman of the Board since 2008. He has over 25 years of experience in the pharmaceutical industry, including serving as the Chief Executive Officer of Celsion Corporation.
Julie McHugh - Independent Director: Julie McHugh joined the Ironwood Board of Directors in 2016. She has more than 25 years of experience in the pharmaceutical and healthcare industries, including serving as the Chief Operating Officer of Endo Pharmaceuticals.
8. Terrance McGuire - Independent Director: Terrance McGuire has been an Independent Director since Ironwood's inception in 1998. He is a co-founder and General Partner of Polaris Partners, a venture capital firm that invests in life sciences and technology companies.
9. Regina Benjamin - Independent Director: Regina Benjamin has been an Independent Director since 2013. She is a physician and health policy expert who previously served as the 18th Surgeon General of the United States.
10. Perre Welner - Independent Director: Perre Welner joined the Ironwood Board of Directors in 2018. He has over 30 years of experience in the pharmaceutical and biotechnology industries, including serving as the Chief Executive Officer of BioClin Therapeutics.
Ironwood Pharmaceuticals inc currently has 100 employees.
|
